{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:27:09Z","timestamp":1791034029548,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["NO1-HB-67129"],"award-info":[{"award-number":["NO1-HB-67129"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["UO1-HL45696"],"award-info":[{"award-number":["UO1-HL45696"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jpainsymman.2010.03.020","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T06:29:52Z","timestamp":1285309792000},"page":"870-882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Hydroxyurea and Acute Painful Crises in Sickle Cell Anemia: Effects on Hospital Length of Stay and Opioid Utilization During Hospitalization, Outpatient Acute Care Contacts, and at Home"],"prefix":"10.1016","volume":"40","author":[{"given":"Samir K.","family":"Ballas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Bauserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswaldo L.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wally R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron A.","family":"Waclawiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2010.03.020_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.hoc.2005.07.008","article-title":"Pain management of sickle cell disease","volume":"19","author":"Ballas","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib2","series-title":"Disorders of hemoglobin: Genetics, pathophysiology, and clinical management","first-page":"671","article-title":"Nature and treatment of the acute\u00a0painful episode in sickle cell disease","author":"Benjamin","year":"2001"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib3","series-title":"Current Issues in Sickle Cell Pain and its Management. Hematology 2007, American Society of Hematology Education Program Book","author":"Ballas","year":"2007"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib4","author":"Ballas"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib5","series-title":"Renaissance of sickle cell disease research in the genomic era","first-page":"99","article-title":"Pain in sickle cell disease: a multidimensional construct","author":"Benjamin","year":"2007"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib6","volume":"vol. 11","author":"Ballas","year":"1998"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib7","series-title":"Guideline for the management of acute and chronic pain in sickle cell disease. American Pain Society Clinical Practice Guidelines Series No. 1","author":"Benjamin","year":"1999"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1526-4637.2009.00601.x","article-title":"Pain syndromes in sickle cell disease: an update","volume":"10","author":"Nicola","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.286.17.2099","article-title":"Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial","volume":"286","author":"Orringer","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib11","first-page":"467","article-title":"Efficacy of zinc therapy in prevention of crisis in sickle cell anemia: a double blind, randomized controlled clinical trial","volume":"43","author":"Gupta","year":"1995","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1348\/135910702760213715","article-title":"Sickle cell disease: pain, coping and quality of life in a study of adults in the UK","volume":"7","author":"Anie","year":"2002","journal-title":"Br J Health Psychol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/0278-6133.23.3.267","article-title":"Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle cell disease","volume":"23","author":"Gil","year":"2004","journal-title":"Health Psychol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jwh.2006.15.146","article-title":"Gender differences in pain and healthcare utilization for adult sickle cell disease patients: the PiSCES project","volume":"15","author":"McClish","year":"2006","journal-title":"J Womens Health"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: the PiSCES project","volume":"3","author":"McClish","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib16","first-page":"254","article-title":"Treatment of sickle cell pain crisis: a clinical trial of diflunisal (Dolobid)","volume":"25","author":"Perlin","year":"1988","journal-title":"Clin Trials J"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajh.2830460108","article-title":"Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis","volume":"46","author":"Perlin","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0196-0644(89)80871-6","article-title":"Comparison of intramuscular analgesic activity of butorphanol and morphine in patients with sickle cell disease","volume":"18","author":"Gonzalez","year":"1989","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00002508-199609000-00006","article-title":"A review of evidence about factors affecting quality of pain management in sickle cell disease","volume":"12","author":"Elander","year":"1996","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib20","first-page":"1","article-title":"Outpatient management of sickle cell pain with chronic opioid pharmacotherapy","volume":"96","author":"Shaiova","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2007-07-089144","article-title":"Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void","volume":"111","author":"Solomon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.V63.4.921.921","article-title":"Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?","volume":"63","author":"Powars","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0933-3657(99)00035-4","article-title":"Predicting the effectiveness of hydroxyurea in individual sickle cell patients","volume":"18","author":"Valafar","year":"2000","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib25","series-title":"National Heart, Lung, and Blood Institute. The management of sickle cell disease","author":"National Institutes of Health","year":"2002"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib26","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood.V72.4.1216.1216","article-title":"Rheologic predictors of the severity of the painful sickle cell crisis","volume":"72","author":"Ballas","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03630269509005824","article-title":"The sickle cell painful crisis in adults: phases and objective signs","volume":"19","author":"Ballas","year":"1995","journal-title":"Hemoglobin"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ajh.20703","article-title":"Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea","volume":"81","author":"Lanzkron","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib29","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V79.8.2154.2154","article-title":"Red cell changes during the evolution of the sickle cell painful crisis","volume":"79","author":"Ballas","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib31","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1537-2995.2006.00679.x","article-title":"Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia","volume":"46","author":"Ballas","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/pbc.20180","article-title":"Variation in hospitalization and hospital length of stay in children with vaso-occlusive crisis in sickle cell disease","volume":"44","author":"Panepinto","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib34","first-page":"192","article-title":"Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease","volume":"99","author":"Ellison","year":"2007","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.20336","article-title":"Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance","volume":"79","author":"Ballas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.21854","article-title":"Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease","volume":"52","author":"Frei-Jones","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib37","first-page":"40","article-title":"Cost of hospitalizations associated with sickle cell disease in the United States","volume":"112","author":"Davis","year":"1997","journal-title":"Public Health Rep"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib38","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMe0901006","article-title":"Revisiting readmissions\u2014changing the incentives for shared accountability","volume":"360","author":"Epstein","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<26::AID-AJH5>3.0.CO;2-F","article-title":"Cost-effectiveness of hydroxyurea in sickle cell anemia","volume":"64","author":"Moore","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ajh.21443","article-title":"The cost of health care for patients with sickle cell disease","volume":"84","author":"Ballas","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib41","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.annemergmed.2007.09.033","article-title":"Meperidine for acute sickle cell pain in the emergency department: revisited controversy","volume":"51","author":"Ballas","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.annemergmed.2007.09.026","article-title":"Use of meperidine as the analgesic of choice in treating pain from acute painful sickle cell crisis","volume":"51","author":"Morgan","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib44","doi-asserted-by":"crossref","unstructured":"Howland MA. Why meperidine should not make a comeback in treating patients with sickle cell disease. 2008; 21:203\u2013205.","DOI":"10.1016\/j.annemergmed.2007.05.021"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01173478","article-title":"The hierarchical factor structure of the Coping Strategies Inventory","volume":"13","author":"Tobin","year":"1989","journal-title":"Cognit Ther Res"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/000992289903800803","article-title":"Low frequency of meperidine associated seizures in sickle cell disease","volume":"38","author":"Nadvi","year":"1999","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clpt.2003.10.007","article-title":"Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease","volume":"75","author":"Kopecky","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib48","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/pbc.20403","article-title":"Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome","volume":"45","author":"Buchanan","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib49","doi-asserted-by":"crossref","first-page":"884a","DOI":"10.1182\/blood.V106.11.3167.3167","article-title":"Morphine induces kidney injury in transgenic sickle cell mice","volume":"106","author":"Weber","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7525-4-59","article-title":"Hydroxyurea and sickle cell anemia: effect on quality of life","volume":"4","author":"Ballas","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jpainsymman.2010.03.020_bib51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539241000518X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539241000518X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:05:07Z","timestamp":1760130307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539241000518X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S088539241000518X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.03.020","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxyurea and Acute Painful Crises in Sickle Cell Anemia: Effects on Hospital Length of Stay and Opioid Utilization During Hospitalization, Outpatient Acute Care Contacts, and at Home","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}